#begin document (ectb_1029_1); part 000
ectb_1029	1	0	A	DT	(TOP(S(NP*	-	-	-	-	-
ectb_1029	1	1	dream	NN	*)	dream	-	3	-	-
ectb_1029	1	2	come	VBN	(VP*	come	04	3	-	-
ectb_1029	1	3	true	JJ	(ADJP*))	-	-	-	-	-
ectb_1029	1	4	?	.	*))	-	-	-	-	-

ectb_1029	1	0	Developments	NNS	(TOP(S(NP(NP*)	-	-	-	-	-
ectb_1029	1	1	such	JJ	(PP*	-	-	-	-	-
ectb_1029	1	2	as	IN	*	-	-	-	-	-
ectb_1029	1	3	the	DT	(NP(NP(NP*	-	-	-	-	-
ectb_1029	1	4	sequencing	NN	*)	-	-	-	-	-
ectb_1029	1	5	of	IN	(PP*	-	-	-	-	-
ectb_1029	1	6	the	DT	(NP*	-	-	-	-	-
ectb_1029	1	7	human	NN	*	-	-	-	-	-
ectb_1029	1	8	genome	NN	*)))	-	-	-	-	-
ectb_1029	1	9	and	CC	*	-	-	-	-	-
ectb_1029	1	10	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	11	rapid	JJ	*	-	-	-	-	-
ectb_1029	1	12	development	NN	*)	-	-	-	-	-
ectb_1029	1	13	of	IN	(PP*	-	-	-	-	-
ectb_1029	1	14	genetic	JJ	(NP*	-	-	-	-	-
ectb_1029	1	15	engineering	NN	*))))))	engineering	-	2	-	-
ectb_1029	1	16	have	VBP	(VP*	have	01	-	-	-
ectb_1029	1	17	spawned	VBN	(VP*	spawn	01	1	-	-
ectb_1029	1	18	biotechnology	NN	(NP(NP*	-	-	-	-	-
ectb_1029	1	19	industries	NNS	*)	industry	-	1	-	-
ectb_1029	1	20	like	IN	(PP*	-	-	-	-	-
ectb_1029	1	21	bioinformatics	NNS	(NP(NP(NP*)	-	-	-	-	-
ectb_1029	1	22	,	,	*	-	-	-	-	-
ectb_1029	1	23	biomaterials	NNS	(NP*)	-	-	-	-	-
ectb_1029	1	24	and	CC	*	-	-	-	-	-
ectb_1029	1	25	pharmaceutical	JJ	(NP*	-	-	-	-	-
ectb_1029	1	26	engineering	NN	*))	engineering	-	2	-	-
ectb_1029	1	27	,	,	*	-	-	-	-	-
ectb_1029	1	28	which	WDT	(SBAR(WHNP*)	-	-	-	-	-
ectb_1029	1	29	have	VBP	(S(VP*	have	01	-	-	-
ectb_1029	1	30	emerged	VBN	(VP*	emerge	02	2	-	-
ectb_1029	1	31	as	IN	(PP*	-	-	-	-	-
ectb_1029	1	32	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	33	rising	VBG	*	rise	01	-	-	-
ectb_1029	1	34	stars	NNS	*)	star	-	2	-	-
ectb_1029	1	35	of	IN	(PP*	-	-	-	-	-
ectb_1029	1	36	21st	JJ	(NP(NML*	-	-	-	-	-
ectb_1029	1	37	-	HYPH	*	-	-	-	-	-
ectb_1029	1	38	century	NN	*)	-	-	-	-	-
ectb_1029	1	39	industry	NN	*)))))))))))))	industry	-	1	-	-
ectb_1029	1	40	.	.	*))	-	-	-	-	-

ectb_1029	1	0	As	IN	(TOP(S(PP*	-	-	-	-	-
ectb_1029	1	1	part	NN	(NP(NP*)	part	-	1	-	-
ectb_1029	1	2	of	IN	(PP*	-	-	-	-	-
ectb_1029	1	3	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	4	government	NN	*	government	-	1	-	-
ectb_1029	1	5	's	POS	*)	-	-	-	-	-
ectb_1029	1	6	efforts	NNS	*	effort	-	1	-	-
ectb_1029	1	7	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	1	8	promote	VB	(VP*	promote	02	1	-	-
ectb_1029	1	9	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	10	biotechnology	NN	*	-	-	-	-	-
ectb_1029	1	11	industry	NN	*)	-	-	-	-	-
ectb_1029	1	12	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	13	Taiwan	NNP	(NP*))))))))))	-	-	-	-	(15)
ectb_1029	1	14	,	,	*	-	-	-	-	-
ectb_1029	1	15	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	16	July	NNP	(NP*	-	-	-	-	-
ectb_1029	1	17	1999	CD	*))	-	-	-	-	-
ectb_1029	1	18	the	DT	(NP(NP*	-	-	-	-	(5
ectb_1029	1	19	Industrial	NNP	*	-	-	-	-	-
ectb_1029	1	20	Technology	NNP	*	-	-	-	-	-
ectb_1029	1	21	Research	NNP	*	-	-	-	-	-
ectb_1029	1	22	Institute	NNP	*)	-	-	-	-	-
ectb_1029	1	23	-LRB-	-LRB-	(NP*	-	-	-	-	-
ectb_1029	1	24	ITRI	NNP	*	-	-	-	-	-
ectb_1029	1	25	-RRB-	-RRB-	*))	-	-	-	-	5)
ectb_1029	1	26	set	VBD	(VP*	set	03	4	-	-
ectb_1029	1	27	up	RP	(PRT*)	-	-	-	-	-
ectb_1029	1	28	the	DT	(NP(NP*	-	-	-	-	(1
ectb_1029	1	29	Biomedical	NNP	*	-	-	-	-	-
ectb_1029	1	30	Engineering	NNP	*	-	-	-	-	-
ectb_1029	1	31	Center	NNP	*)	-	-	-	-	-
ectb_1029	1	32	-LRB-	-LRB-	(NP*	-	-	-	-	-
ectb_1029	1	33	BMEC	NNP	*	-	-	-	-	-
ectb_1029	1	34	-RRB-	-RRB-	*))	-	-	-	-	1)
ectb_1029	1	35	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	1	36	actively	RB	(ADVP*)	-	-	-	-	-
ectb_1029	1	37	develop	VB	(VP*	develop	02	1	-	-
ectb_1029	1	38	biomedical	JJ	(NP*	-	-	-	-	-
ectb_1029	1	39	engineering	NN	*	engineering	-	2	-	-
ectb_1029	1	40	technologies	NNS	*)))))	technology	-	1	-	-
ectb_1029	1	41	.	.	*))	-	-	-	-	-

ectb_1029	1	0	Biochips	NNS	(TOP(S(NP*)	-	-	-	-	-
ectb_1029	1	1	are	VBP	(VP*	be	01	2	-	-
ectb_1029	1	2	one	CD	(NP(NP*)	-	-	-	-	-
ectb_1029	1	3	of	IN	(PP*	-	-	-	-	-
ectb_1029	1	4	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	5	core	NN	*	core	-	3	-	-
ectb_1029	1	6	technologies	NNS	*)	technology	-	1	-	-
ectb_1029	1	7	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	8	the	DT	(NP*	-	-	-	-	-
ectb_1029	1	9	field	NN	*))))))	field	-	3	-	-
ectb_1029	1	10	.	.	*))	-	-	-	-	-

ectb_1029	1	0	BMEC	NNP	(TOP(S(NP(NML*	-	-	-	-	(1)
ectb_1029	1	1	general	JJ	*	-	-	-	-	-
ectb_1029	1	2	director	NN	*)	director	-	1	-	-
ectb_1029	1	3	Dr.	NNP	*	-	-	-	-	-
ectb_1029	1	4	Johnsee	NNP	*	-	-	-	-	-
ectb_1029	1	5	Lee	NNP	*)	-	-	-	-	-
ectb_1029	1	6	says	VBZ	(VP*	say	01	1	-	-
ectb_1029	1	7	that	IN	(SBAR*	-	-	-	-	-
ectb_1029	1	8	the	DT	(S(NP(NP(NP*	-	-	-	-	(5|(31
ectb_1029	1	9	ITRI	NNP	*	-	-	-	-	-
ectb_1029	1	10	's	POS	*)	-	-	-	-	5)
ectb_1029	1	11	four	CD	(NML*	-	-	-	-	-
ectb_1029	1	12	-	HYPH	*	-	-	-	-	-
ectb_1029	1	13	year	NN	*)	-	-	-	-	-
ectb_1029	1	14	R&D	NN	*	-	-	-	-	-
ectb_1029	1	15	program	NN	*)	program	-	3	-	-
ectb_1029	1	16	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	17	biochip	NN	(NP*	-	-	-	-	-
ectb_1029	1	18	applications	NNS	*	-	-	-	-	-
ectb_1029	1	19	and	CC	*	-	-	-	-	-
ectb_1029	1	20	technology	NN	*)))	technology	-	1	-	31)
ectb_1029	1	21	is	VBZ	(VP*	be	01	1	-	-
ectb_1029	1	22	now	RB	(ADVP*)	-	-	-	-	-
ectb_1029	1	23	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	24	its	PRP$	(NP*	-	-	-	-	(31)
ectb_1029	1	25	second	JJ	*	-	-	-	-	-
ectb_1029	1	26	year	NN	*))))))	-	-	-	-	-
ectb_1029	1	27	.	.	*))	-	-	-	-	-

ectb_1029	1	0	Its	PRP$	(TOP(S(NP*	-	-	-	-	(31)
ectb_1029	1	1	initial	JJ	*	-	-	-	-	-
ectb_1029	1	2	objectives	NNS	*)	objective	-	1	-	-
ectb_1029	1	3	are	VBP	(VP*	be	03	-	-	-
ectb_1029	1	4	mainly	RB	(ADVP*)	-	-	-	-	-
ectb_1029	1	5	focused	VBN	(VP*	focus	01	2	-	-
ectb_1029	1	6	on	IN	(PP*	-	-	-	-	-
ectb_1029	1	7	developing	VBG	(S(VP*	develop	02	1	-	-
ectb_1029	1	8	sensor	NN	(NP*	-	-	-	-	-
ectb_1029	1	9	chips	NNS	*)	chip	-	11	-	-
ectb_1029	1	10	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	1	11	screen	VB	(VP*	screen	01	1	-	-
ectb_1029	1	12	for	IN	(PP*	-	-	-	-	-
ectb_1029	1	13	infectious	JJ	(NP*	-	-	-	-	-
ectb_1029	1	14	diseases	NNS	*))))))))	-	-	-	-	-
ectb_1029	1	15	,	,	*	-	-	-	-	-
ectb_1029	1	16	while	IN	(SBAR*	-	-	-	-	-
ectb_1029	1	17	later	JJR	(S(NP*	-	-	-	-	-
ectb_1029	1	18	goals	NNS	*)	goal	-	1	-	-
ectb_1029	1	19	will	MD	(VP*	-	-	-	-	-
ectb_1029	1	20	be	VB	(VP*	be	01	2	-	-
ectb_1029	1	21	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	1	22	develop	VB	(VP*	develop	02	1	-	-
ectb_1029	1	23	technologies	NNS	(NP(NP*)	technology	-	1	-	-
ectb_1029	1	24	to	TO	(SBAR(S(VP*	-	-	-	-	-
ectb_1029	1	25	test	VB	(VP*	test	01	2	-	-
ectb_1029	1	26	for	IN	(PP*	-	-	-	-	-
ectb_1029	1	27	genetic	JJ	(NP*	-	-	-	-	-
ectb_1029	1	28	diseases	NNS	*	-	-	-	-	-
ectb_1029	1	29	and	CC	*	-	-	-	-	-
ectb_1029	1	30	cancers	NNS	*))))))))))))))))	cancer	-	1	-	-
ectb_1029	1	31	.	.	*))	-	-	-	-	-

ectb_1029	1	0	As	RB	(TOP(S(ADVP(ADVP*	-	-	-	-	-
ectb_1029	1	1	well	RB	*)	-	-	-	-	-
ectb_1029	1	2	as	IN	(PP*	-	-	-	-	-
ectb_1029	1	3	this	DT	(NP*	-	-	-	-	(1
ectb_1029	1	4	new	JJ	*	-	-	-	-	-
ectb_1029	1	5	research	NN	*	-	-	-	-	-
ectb_1029	1	6	establishment	NN	*)))	-	-	-	-	1)
ectb_1029	1	7	,	,	*	-	-	-	-	-
ectb_1029	1	8	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	9	the	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	10	two	CD	*	-	-	-	-	-
ectb_1029	1	11	years	NNS	*)	-	-	-	-	-
ectb_1029	1	12	since	IN	(PP*	-	-	-	-	-
ectb_1029	1	13	September	NNP	(NP*	-	-	-	-	-
ectb_1029	1	14	1998	CD	*))))	-	-	-	-	-
ectb_1029	1	15	three	CD	(NP(NP*	-	-	-	-	-
ectb_1029	1	16	commercial	JJ	*	-	-	-	-	-
ectb_1029	1	17	companies	NNS	*))	company	-	1	-	-
ectb_1029	1	18	have	VBP	(VP*	have	01	-	-	-
ectb_1029	1	19	been	VBN	(VP*	be	03	-	-	-
ectb_1029	1	20	set	VBN	(VP*	-	-	-	-	-
ectb_1029	1	21	up	RP	(PRT*)	-	-	-	-	-
ectb_1029	1	22	in	IN	(PP*	-	-	-	-	-
ectb_1029	1	23	Taiwan	NNP	(NP*))	-	-	-	-	(15)
ectb_1029	1	24	to	TO	(S(VP*	-	-	-	-	-
ectb_1029	1	25	make	VB	(VP*	make	01	2	-	-
ectb_1029	1	26	biochips	NNS	(NP*))))	-	-	-	-	-
ectb_1029	1	27	:	:	*	-	-	-	-	-
ectb_1029	1	28	U	NNP	(NP(NP(NML*	-	-	-	-	-
ectb_1029	1	29	-	HYPH	*	-	-	-	-	-
ectb_1029	1	30	Vision	NNP	*)	-	-	-	-	-
ectb_1029	1	31	Biotech	NNP	*)	-	-	-	-	-
ectb_1029	1	32	,	,	*	-	-	-	-	-
ectb_1029	1	33	Taiwan	NNP	(NP*	-	-	-	-	-
ectb_1029	1	34	Genome	NNP	*	-	-	-	-	-
ectb_1029	1	35	Sciences	NNPS	*)	-	-	-	-	-
ectb_1029	1	36	and	CC	*	-	-	-	-	-
ectb_1029	1	37	DR.	NNP	(NP*	-	-	-	-	(37
ectb_1029	1	38	Chip	NNP	*	-	-	-	-	-
ectb_1029	1	39	Biotechnology	NNP	*)))))	-	-	-	-	37)
ectb_1029	1	40	.	.	*))	-	-	-	-	-

ectb_1029	1	0	Of	IN	(TOP(S(PP*	-	-	-	-	-
ectb_1029	1	1	these	DT	(NP*))	-	-	-	-	-
ectb_1029	1	2	,	,	*	-	-	-	-	-
ectb_1029	1	3	DR.	NNP	(NP*	-	-	-	-	(37
ectb_1029	1	4	Chip	NNP	*)	-	-	-	-	37)
ectb_1029	1	5	attracted	VBD	(VP*	attract	01	1	-	-
ectb_1029	1	6	much	JJ	(NP*	-	-	-	-	-
ectb_1029	1	7	attention	NN	*)	attention	-	3	-	-
ectb_1029	1	8	this	DT	(NP*	-	-	-	-	-
ectb_1029	1	9	year	NN	*)	-	-	-	-	-
ectb_1029	1	10	when	WRB	(SBAR(WHADVP*)	-	-	-	-	-
ectb_1029	1	11	it	PRP	(S(NP*)	-	-	-	-	(37)
ectb_1029	1	12	developed	VBD	(VP*	develop	02	1	-	-
ectb_1029	1	13	a	DT	(NP(NP*	-	-	-	-	-
ectb_1029	1	14	chip	NN	*)	chip	-	11	-	-
ectb_1029	1	15	to	TO	(SBAR(S(VP*	-	-	-	-	-
ectb_1029	1	16	detect	VB	(VP*	detect	01	1	-	-
ectb_1029	1	17	enteroviruses	NNS	(NP(NP*)	-	-	-	-	-
ectb_1029	1	18	,	,	*	-	-	-	-	-
ectb_1029	1	19	a	DT	(SBAR(WHNP(NP*	-	-	-	-	-
ectb_1029	1	20	deadly	JJ	*	-	-	-	-	-
ectb_1029	1	21	epidemic	NN	*)	-	-	-	-	-
ectb_1029	1	22	of	IN	(WHPP*	-	-	-	-	-
ectb_1029	1	23	which	WDT	(WHNP*)))	-	-	-	-	-
ectb_1029	1	24	has	VBZ	(S(VP*	have	01	-	-	-
ectb_1029	1	25	gripped	VBN	(VP*	grip	01	2	-	-
ectb_1029	1	26	Taiwan	NNP	(NP*)	-	-	-	-	(15)
ectb_1029	1	27	over	IN	(PP*	-	-	-	-	-
ectb_1029	1	28	the	DT	(NP*	-	-	-	-	-
ectb_1029	1	29	last	JJ	*	-	-	-	-	-
ectb_1029	1	30	two	CD	*	-	-	-	-	-
ectb_1029	1	31	years	NNS	*))))))))))))))))	-	-	-	-	-
ectb_1029	1	32	.	.	*))	-	-	-	-	-

#end document
